|Articles|January 28, 2011

Featured Search - 18F-FDG PET Predicts Outcome in Pediatric Brain Stem Glioma

Examination of baseline scans from a glioma-treatment trial of the Pediatric Brain Tumor Consortium shows that the pattern and intensity of uptake in 18F FDG uptake in children diagnosed with brainstem glioma correlated with overall and progression-free survival rates.

Top news from a Jan. 27 featured radiology search on SearchMedica: nuclear

Evaluation of 18F-FDG PET and MRI Associations in Pediatric Diffuse Intrinsic Brain Stem Glioma: A Report from the Pediatric Brain Tumor ConsortiumThe Journal of Nuclear Medicine | Feb 1, 2011 (Free abstract. Full text $15)

Examination of baseline scans from a glioma-treatment trial of the Pediatric Brain Tumor Consortium shows that the pattern and intensity of uptake in ^18FFDG PET scans in children diagnosed with brainstem glioma correlated with overall and progression-free survival rates.

Related content from Diagnostic Imaging:

FDG-PET/CT identifies aortic dissection

PET/CT imaging with FDG can identify when a tear in the wall of the aorta causes blood to flow between the wall's layers and forces the layers apart.

FDG-PET/CT provides added value in routine multiple imaging scans

In patients with suspected infection and no known history of cancer FDG-PET/CT can be a useful tool for localizing the infectious disease.

Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.

Related to this article

September 18th, 2026

Foundation Model-Based Chest X-Ray AI Software Gets FDA Nod

Reportedly one of the first FDA-cleared chest X-ray AI software platforms derived from a foundation model, the Chest Xray software facilitates detection and localization of lung nodules, pneumothorax, mediastinal abnormalities and other thoracic abnormalities.

September 18th, 2026

FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET

Incorporating structural MRI to improve PET imaging resolution, the MICSI-PET software also offers automated Centiloid quantification from amyloid PET scans.

September 18th, 2026

Does kV Still Matter in Photon-Counting CT?

Emerging research demonstrates the increasing stability of attenuation on clinically relevant VMIs with photon-counting CT and a redefined role of kV that may have implications for longitudinal quantitative CT.

September 17th, 2026

Prostate MRI Study Links Lower ACD Values on DWI to Higher Long-Term Risk of Distant Metastases

For patients with intermediate-risk prostate cancer, those with lower apparent diffusion coefficient (ADC) values on pre-treatment DWI MRI had a fourfold higher prevalence of distant metastasis in a study with a 10.3-year median follow-up.

September 17th, 2026

The Reading Room Podcast: Assessing the Current Landscape of AI and Reimbursement in Radiology, Part 2

In the second of a two-part podcast episode, Lauren Nicola, MD, Christoph Wald, MD, PhD, MBA, and Peter Shen discuss challenges with evaluating value and ROI for AI software, the physician time required to do so, and possible solutions to facilitate improved clarity and consistency with AI reimbursement.

September 16th, 2026

Breast Imaging in Focus: Key Pearls from New Guidelines on Proliferative Breast Lesions with Atypia and LCIS

In the latest episode of her “Breast Imaging in Focus” series, Manisha Bahl, MD, MPH, FSBI, offer pertinent takeaways for breast radiologists from recently issued guidelines for addressing proliferative breast lesions with atypia and lobular carcinoma in situ (LCIS).

September 15th, 2026

Brain MRI Study Reveals Higher Brain Age Gap and White Matter Hyperintensity for Those in Disadvantaged Neighborhoods

In a study involving over 2,800 people who had brain MRI scans, researchers found that people in the most disadvantaged neighborhoods had 37 percent higher white matter hyperintensity volume (WMHV) on average in comparison to people in the least disadvantaged areas.

September 15th, 2026

CT Radiation Dosing: Where Things Stand, Part 2

In the second of a two-part interview, Kalpana Kanal, PhD, and Mahadevappa Mahesh, MS, PhD, FAPPM, FACR, discussed future directions for research on CT radiation dosing, including the potential of indication-specific diagnostic reference levels (DRLs).

Featured Search - 18F-FDG PET Predicts Outcome in Pediatric Brain Stem Glioma

Related to this article

Trending on Diagnostic Imaging

Prostate MRI Study Links Lower ACD Values on DWI to Higher Long-Term Risk of Distant Metastases

FDA Clears Software That Combines MRI Enhancement of PET Imaging with Automated Quantification of Amyloid and Tau PET

Brain MRI Study Reveals Higher Brain Age Gap and White Matter Hyperintensity for Those in Disadvantaged Neighborhoods

Molecular Imaging in Focus: Can the Newly FDA-Approved PET Agent Floretyrosine F18 Have an Impact for Glioma Imaging?

The Reading Room Podcast: Assessing the Current Landscape of AI and Reimbursement in Radiology, Part 2